Chronic Rhinosinusitis with Nasal Polyps (CRSwNP) Overview
Learn About Chronic Rhinosinusitis with Nasal Polyps (CRSwNP)
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
New York University
Richard Lebowitz is an Otolaryngologist in New York, New York. Dr. Lebowitz and is rated as an Advanced provider by MediFind in the treatment of Chronic Rhinosinusitis with Nasal Polyps (CRSwNP). His top areas of expertise are Chronic Rhinosinusitis with Nasal Polyps (CRSwNP), Sinusitis, Cerebrospinal Fluid Leak, Endoscopic Transnasal Transsphenoidal Surgery, and Endoscopy.
Weill Medical College Of Cornell
Abtin Tabaee is an Otolaryngologist in New York, New York. Dr. Tabaee and is rated as a Distinguished provider by MediFind in the treatment of Chronic Rhinosinusitis with Nasal Polyps (CRSwNP). His top areas of expertise are Cerebrospinal Fluid Leak, Chronic Rhinosinusitis with Nasal Polyps (CRSwNP), Sinusitis, Septoplasty, and Endoscopic Transnasal Transsphenoidal Surgery.
Trustees Of Columbia University In The City Of New York
David Gudis is an Otolaryngologist and a Pediatric Otolaryngologist in New York, New York. Dr. Gudis and is rated as a Distinguished provider by MediFind in the treatment of Chronic Rhinosinusitis with Nasal Polyps (CRSwNP). His top areas of expertise are Sinusitis, Chronic Rhinosinusitis with Nasal Polyps (CRSwNP), Ethmoiditis, Endoscopy, and Septoplasty.
Summary: This study aims to evaluate the safety and effectiveness of Xolair® in patients with chronic rhinosinusitis with nasal polyps in routine clinical practice.
Summary: The goal of this clinical trial is to understand the mechanisms leading to olfactory dysfunction (OD) in chronic rhinosinusitis (CRS). The main questions it aims to answer are: * Is the type 2 inflammation impacting the olfactory epithelium regeneration, leading to OD? * Does a treatment interfering with one of the major T2 inflammatory cytokines, have an impact on the mechanisms of OD in CRS? Par...